• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

经皮冠状动脉介入治疗后肝素诱导的血小板减少症导致的冠状动脉血栓形成：易漏诊，难预防。

Coronary thrombosis due to heparin-induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent.

作者信息

Mele Marco, Iacoviello Massimo, Casavecchia Grazia, Tricarico Lucia, Brunetti Natale Daniele

机构信息

Department of Cardiology Policlinico Riuniti Foggia Italy.

Department of Cardiology University of Foggia Foggia Italy.

出版信息

Clin Case Rep. 2020 Nov 7;9(1):90-92. doi: 10.1002/ccr3.3448. eCollection 2021 Jan.

DOI:10.1002/ccr3.3448
PMID:33489138
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7813037/
Abstract

In case of unexplained post-PCI coronary thrombosis, a HIT should be always considered. A pragmatic approach with bivalirudin may be reasonable, even in absence of confirmed laboratory diagnosis.

摘要

对于PCI术后不明原因的冠状动脉血栓形成，应始终考虑肝素诱导的血小板减少症（HIT）。即使在没有确诊的实验室诊断的情况下，使用比伐卢定的务实方法可能是合理的。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/526a/7813037/6cc7caa9bc02/CCR3-9-90-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/526a/7813037/6cc7caa9bc02/CCR3-9-90-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/526a/7813037/6cc7caa9bc02/CCR3-9-90-g001.jpg

相似文献

1
Coronary thrombosis due to heparin-induced thrombocytopenia after percutaneous coronary intervention: Easy to miss, uneasy to prevent.经皮冠状动脉介入治疗后肝素诱导的血小板减少症导致的冠状动脉血栓形成：易漏诊，难预防。
Clin Case Rep. 2020 Nov 7;9(1):90-92. doi: 10.1002/ccr3.3448. eCollection 2021 Jan.
2
The anticoagulant therapy with bivalirudin to assist in the performance of percutaneous coronary intervention in patients with heparin-induced thrombocytopenia (ATBAT) study: main results.比伐卢定抗凝治疗辅助肝素诱导的血小板减少症患者进行经皮冠状动脉介入治疗（ATBAT）研究：主要结果
J Invasive Cardiol. 2003 Nov;15(11):611-6.
3
Bivalirudin versus heparin with or without glycoprotein IIb/IIIa inhibitors in patients with STEMI undergoing primary percutaneous coronary intervention: pooled patient-level analysis from the HORIZONS-AMI and EUROMAX trials.比伐卢定与肝素联合或不联合糖蛋白 IIb/IIIa 抑制剂用于行直接经皮冠状动脉介入治疗的 ST 段抬高型心肌梗死患者：来自 HORIZONS-AMI 和 EUROMAX 试验的汇总患者水平分析。
J Am Coll Cardiol. 2015 Jan 6;65(1):27-38. doi: 10.1016/j.jacc.2014.10.029.
4
A journey through anticoagulant therapies in the treatment of left ventricular thrombus in post-COVID-19 heparin-induced thrombocytopenia: a case report.COVID-19 后肝素诱导血小板减少症抗凝治疗左心室血栓的旅程：一例报告。
Hematology. 2022 Dec;27(1):318-321. doi: 10.1080/16078454.2022.2043572.
5
Missed Heparin-Induced Thrombocytopenia (HIT) Diagnosis in a Patient with Acute Stent Thrombosis.一名急性支架血栓形成患者肝素诱导的血小板减少症（HIT）诊断漏诊
Am J Case Rep. 2019 May 28;20:753-757. doi: 10.12659/AJCR.914988.
6
Effect of Post-Primary Percutaneous Coronary Intervention Bivalirudin Infusion on Acute Stent Thrombosis: Meta-Analysis of Randomized Controlled Trials.经皮冠状动脉介入治疗后比伐卢定输注对急性支架血栓形成的影响：随机对照试验的荟萃分析。
JACC Cardiovasc Interv. 2016 Jul 11;9(13):1313-20. doi: 10.1016/j.jcin.2016.03.031. Epub 2016 Jun 15.
7
Direct thrombin inhibition during percutaneous coronary intervention in patients with heparin-induced thrombocytopenia.肝素诱导的血小板减少症患者经皮冠状动脉介入治疗期间的直接凝血酶抑制
Expert Rev Cardiovasc Ther. 2007 Jan;5(1):57-68. doi: 10.1586/14779072.5.1.57.
8
A case of heparin-induced thrombocytopenia with subacute stent thrombosis, multiple cerebral infarction, and acute limb ischemia.1例肝素诱导的血小板减少症合并亚急性支架血栓形成、多发性脑梗死和急性肢体缺血。
J Cardiol Cases. 2017 Mar 7;15(5):145-149. doi: 10.1016/j.jccase.2016.12.013. eCollection 2017 May.
9
Bivalirudin vs heparin with or without tirofiban during primary percutaneous coronary intervention in acute myocardial infarction: the BRIGHT randomized clinical trial.比伐卢定与肝素联合或不联合替罗非班用于急性心肌梗死患者经皮冠状动脉介入治疗的 BRIGHT 随机临床试验。
JAMA. 2015 Apr 7;313(13):1336-46. doi: 10.1001/jama.2015.2323.
10
Effectiveness and safety of bivalirudin in elderly patients with coronary artery disease undergoing percutaneous coronary intervention: A real-world study.比伐卢定在接受经皮冠状动脉介入治疗的老年冠心病患者中的有效性和安全性：一项真实世界研究。
Catheter Cardiovasc Interv. 2022 May;99 Suppl 1:1448-1455. doi: 10.1002/ccd.30099. Epub 2022 Jan 25.

引用本文的文献

1
Near fatal stent thrombosis in an aneurysmatic RCX as first manifestation of heparin induced thrombocytopenia (HIT) without thrombocytopenia.RCX 支架内发生接近致命性血栓形成，为肝素诱导的血小板减少症（HIT）的首发表现，且血小板计数正常。
BMC Cardiovasc Disord. 2021 Dec 31;21(1):624. doi: 10.1186/s12872-021-02442-3.

本文引用的文献

1
2018 ESC/EACTS Guidelines on myocardial revascularization.2018年欧洲心脏病学会/欧洲心胸外科学会心肌血运重建指南。
EuroIntervention. 2019 Feb 20;14(14):1435-1534. doi: 10.4244/EIJY19M01_01.
2
2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European Society of Cardiology (ESC).2017年欧洲心脏病学会（ESC）ST段抬高型急性心肌梗死患者管理指南：欧洲心脏病学会（ESC）ST段抬高型急性心肌梗死患者管理工作组
Eur Heart J. 2018 Jan 7;39(2):119-177. doi: 10.1093/eurheartj/ehx393.
3
CLINICAL PRACTICE. Heparin-Induced Thrombocytopenia.
临床实践。肝素诱导的血小板减少症。
N Engl J Med. 2015 Jul 16;373(3):252-61. doi: 10.1056/NEJMcp1411910.
4
Impact of heparin-induced thrombocytopenia on acute coronary artery thrombosis in patients undergoing PCI.
Thromb Haemost. 2014 Sep 2;112(3):624-6. doi: 10.1160/TH13-11-0936. Epub 2014 Jun 12.
5
Acute left main occlusion during percutaneous coronary intervention associated with heparin induced thrombocytopenia with thrombosis syndrome.经皮冠状动脉介入治疗期间急性左主干闭塞伴肝素诱导的血小板减少伴血栓形成综合征。
J Interv Cardiol. 2005 Apr;18(2):139-44. doi: 10.1111/j.1540-8183.2005.04070.x.
6
Obstinate thrombosis during percutaneous coronary intervention in a case with heparin-induced thrombocytopenia with thrombosis syndrome successfully treated by argatroban anticoagulant therapy.阿加曲班抗凝治疗成功治愈1例肝素诱导的血小板减少伴血栓形成综合征患者经皮冠状动脉介入治疗期间的顽固性血栓形成
Catheter Cardiovasc Interv. 2003 Jul;59(3):351-4. doi: 10.1002/ccd.10536.
7
Temporal aspects of heparin-induced thrombocytopenia.肝素诱导的血小板减少症的时间因素。
N Engl J Med. 2001 Apr 26;344(17):1286-92. doi: 10.1056/NEJM200104263441704.